$2.47
-0.02 (-0.80%)
Open$2.51
Previous Close$2.49
Day High$2.55
Day Low$2.35
52W High$26.12
52W Low$1.79
Volume—
Avg Volume251.6K
Market Cap11.26M
P/E Ratio—
EPS$-39.60
SectorBiotechnology
Analyst Ratings
Strong Buy
9 analysts
Price Target
+929.6% upside
Current
$2.47
$2.47
Target
$25.43
$25.43
$14.54
$25.43 avg
$32.33
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 2.53M | 2.25M | 2.34M |
| Net Income | -604,093 | -536,841 | -566,432 |
| Profit Margin | -23.9% | -23.9% | -24.2% |
| EBITDA | -828,287 | -680,626 | -721,197 |
| Free Cash Flow | -326,986 | -310,260 | -424,378 |
| Rev Growth | -6.1% | -2.1% | -7.6% |
| Debt/Equity | 0.51 | 0.64 | 0.68 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $210.39 | -0.18% | 88.1 | 372.39B |
| AMGN | Amgen Inc | $326.31 | -2.95% | 23.0 | 179.23B |
| GILD | Gilead Sciences Inc | $129.58 | -1.88% | 17.4 | 160.50B |
| VRTX | Vertex Pharmaceuticals Inc | $436.95 | -2.99% | 26.4 | 114.32B |
| REGN | Regeneron Pharmaceuticals | $698.25 | -2.05% | 16.7 | 73.89B |
| ALNY | Alnylam Pharmaceuticals Inc | $286.98 | -2.20% | 66.6 | 38.43B |